Drugs / axomadol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01043263 | Dec 2009 → Jun 2011 | chronic pain syndrome | Grünenthal GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | axomadol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01043263 ↗ |
| Known as | EN3324 | “The purpose of this study is to determine the efficacy and safety of EN3324 (axomadol) in subjects with moderate to severe chronic low back pain” NCT01043263 ↗ |